|1.||Pei, Yuanying: 2 articles (01/2009 - 09/2006)|
|2.||Fang, Chao: 2 articles (09/2006 - 01/2006)|
|3.||Shi, Bin: 2 articles (09/2006 - 01/2006)|
|4.||Zhu, Saijie: 1 article (01/2009)|
|5.||Jiang, Yanyan: 1 article (01/2009)|
|6.||Hong, Minghuang: 1 article (01/2009)|
|7.||Tang, Guotao: 1 article (01/2009)|
|8.||Hong, Ming-Huang: 1 article (01/2006)|
|9.||Chen, Hong-Zhuan: 1 article (01/2006)|
|10.||Wu, Jiang: 1 article (01/2006)|
01/01/2006 - "The results of the present study showed PEG-PHDCA nanoparticles with higher MePEG molecular weight and smaller particle size could achieve higher in vivo tumor targeting efficiency."
06/01/2001 - "Compared with PHDCA nanoparticles and free rHuTNF-alpha, PEG-PHDCA nanoparticles loaded with rHuTNF-alpha showed higher antitumor potency at the same dose, which might be related to its higher accumulation in tumor tissues and longer plasma circulation time. "
06/01/2001 - "Our experimental results showed that PEG-PHDCA nanoparticles could extend the half-life of rHuTNF-alpha to 7.42 h and obviously change the protein biodistribution in tissues, and in particular, increase accumulation of rHuTNF-alpha in tumor. "
11/05/2004 - "A comparative biodistribution study of Doxorubicin-loaded and unloaded PEG-PHDCA nanospheres was also performed in the tumor-bearing group. "
09/01/2006 - "At last, the tumor inhibition rate of PEG5000-PHDCA niosomes (92.5 nm) at a dose of 2 mg/kg was five times that of HCPT injection at 4 mg/kg. The stealth effects of the PEG-PHDCA niosomes and the enhanced stability of lactone form of HCPT were accountable for the powerful antitumor effects of niosomes."
10/30/2001 - "Based on their blood long-circulating characteristics, these PEGylated particles made by the amphiphilic copolymer poly [methoxy poly(ethylene glycol) cyanoacrylate-co-hexadecyl cyanoacrylate] (PEG-PHDCA), showed comparatively conventional non-PEGylated nanoparticles, a higher uptake by the spleen and the brain which are both the target tissues of PrPres accumulation in scrapie infected animals."
|1.||poly (methoxypolyethyleneglycol cyanoacrylate-co-n-hexadecyl cyanoacrylate)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|8.||Ethylene Glycol (Monoethylene Glycol)
|9.||Transferrin (beta 2 Transferrin)
|10.||Transferrin Receptors (Transferrin Receptor)